Matches in Nanopublications for { ?s ?p "[Furthermore, although the carriage rate of IL1RN*2 was higher in HSPN (46.5%) than average IgAN patients (26.8%; P < 0.01), there was no significant difference in the carriage rate of IL1RN*2 between HSPN and those IgAN patients with recurrent gross hematuria (42.8%l P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_assertion description "[Furthermore, although the carriage rate of IL1RN*2 was higher in HSPN (46.5%) than average IgAN patients (26.8%; P < 0.01), there was no significant difference in the carriage rate of IL1RN*2 between HSPN and those IgAN patients with recurrent gross hematuria (42.8%l P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_provenance.